Arcosa, Inc. is 3.4x more valuable than Proto Labs Inc by market capitalization ($6.03 B vs $1.76 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PRLB | ACA |
|---|---|---|
| Market cap | $1.76 B | $6.03 B |
| US-listed rank | #2187 | #1261 |
| Revenue (latest FY) | $344.49M | $2.88B |
| Net income (latest FY) | $21.24M | $208.40M |
| Net margin | 6.2% | 7.2% |
| P/E (trailing FY) | 82.6 | 28.9 |
| SEC filings | 878 | 632 |
Arcosa, Inc. is 3.4x more valuable than Proto Labs Inc by market capitalization ($6.03 B vs $1.76 B).
In their latest fiscal years, Proto Labs Inc reported $344.49M in revenue while Arcosa, Inc. reported $2.88B.
Full pages: Proto Labs Inc and Arcosa, Inc., or browse the full rankings.